BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12473517)

  • 1. Epigenetics in cancer: implications for early detection and prevention.
    Verma M; Srivastava S
    Lancet Oncol; 2002 Dec; 3(12):755-63. PubMed ID: 12473517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection and risk assessment: proceedings and recommendations from the Workshop on Epigenetics in Cancer Prevention.
    Verma M; Dunn BK; Ross S; Jain P; Wang W; Hayes R; Umar A
    Ann N Y Acad Sci; 2003 Mar; 983():298-319. PubMed ID: 12724234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cancer epigenetics].
    Chang DK
    Korean J Gastroenterol; 2004 Jul; 44(1):1-12. PubMed ID: 15266127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics and cancer.
    Verma M; Maruvada P; Srivastava S
    Crit Rev Clin Lab Sci; 2004; 41(5-6):585-607. PubMed ID: 15603512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro transformation models: modeling human cancer.
    Heeg S; Doebele M; von Werder A; Opitz OG
    Cell Cycle; 2006 Mar; 5(6):630-4. PubMed ID: 16582608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer epigenetics: an introduction.
    Kanwal R; Gupta K; Gupta S
    Methods Mol Biol; 2015; 1238():3-25. PubMed ID: 25421652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation and cancer.
    Das PM; Singal R
    J Clin Oncol; 2004 Nov; 22(22):4632-42. PubMed ID: 15542813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy.
    Worm J; Guldberg P
    J Oral Pathol Med; 2002 Sep; 31(8):443-9. PubMed ID: 12220350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer epigenetics.
    Taby R; Issa JP
    CA Cancer J Clin; 2010; 60(6):376-92. PubMed ID: 20959400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular cancer biology--from research to clinical practice].
    Nielsen FC
    Ugeskr Laeger; 2003 Feb; 165(9):897-900. PubMed ID: 12661511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic changes in cancer.
    Iacobuzio-Donahue CA
    Annu Rev Pathol; 2009; 4():229-49. PubMed ID: 18840073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered primary chromatin structures and their implications in cancer development.
    Ferraro A
    Cell Oncol (Dordr); 2016 Jun; 39(3):195-210. PubMed ID: 27007278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update.
    LlinĂ s-Arias P; Esteller M
    Open Biol; 2017 Sep; 7(9):. PubMed ID: 28931650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic research in prostate cancer: molecular biology.
    Effert PJ; Strohmeyer TG
    Acta Urol Belg; 1994 Apr; 62(1):15-21. PubMed ID: 8197925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation in cancer: a gene silencing mechanism and the clinical potential of its biomarkers.
    Fukushige S; Horii A
    Tohoku J Exp Med; 2013 Mar; 229(3):173-85. PubMed ID: 23419314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes.
    Esteller M
    Br J Cancer; 2006 Jan; 94(2):179-83. PubMed ID: 16404435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excavating relics of DNA methylation changes during the development of neoplasia.
    Hsiao SH; Huang TH; Leu YW
    Semin Cancer Biol; 2009 Jun; 19(3):198-208. PubMed ID: 19429484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Insights into Cancer Epigenetics: Gene Promoter Hypermethylation Emerges as a Potential Biomarker for Cancer Detection.
    Clark SJ; Molloy PL
    Cancer Res; 2022 Apr; 82(8):1461-1463. PubMed ID: 35425958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.